Regulatory approval is the midpoint of the evidence journey — not the end.
#PhaseIV, #Pharmacovigilance, #RealWorldEvidence. All mandatory. All being held to higher standards.
In March 2026, ICH M14 raised the bar for post-marketing observational research significantly.
#ClinicalResearch #CRO